Mar 23, 2026 7:11 PM
Abandoning established pharmaceutical products for a "staking-driven revenue model" based on digital tokens isn't a visionary pivot, but a desperate gamble that replaces tangible value with speculative protocol activity. How can a company generate sustainable returns without traditional business operations?
This summary was generated by AI
NovaBay Stock•Crypto Self Governance•NovaBay Crypto Strategy•NovaBay•SKY Token•Defi•Stablecoin•SKY Protocol•NBY
Comments
Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy


